Epidemiological and microbiological profiles of microbial keratitis in a tertiary eye center in Eastern India (Bihar)

Indian J Ophthalmol. 2023 Nov;71(11):3506-3512. doi: 10.4103/IJO.IJO_1605_23.

Abstract

Purpose: To determine the demography, risk factors, and causative organisms of microbial keratitis (MK) in Bihar, an eastern state of India.

Design: Retrospective study.

Methods: We reviewed the demographic, clinical, and microbiological data of 2303 patients with MK (non-viral) presenting between January 2019 and December 2022.

Results: This study revealed a predominance of males (65.0%) compared to females (34.9%), with a mean age of 48.4 ± 16.5 years. The majority of patients (63.1%) presented after 2 weeks from the onset of symptoms. The most common risk factor observed was corneal injury (58.1%), followed by ocular surface diseases (13.6%) and diabetes mellitus (13.3%). The majority of patients (73.16%) were involved in agriculture. Prior to presentation, almost all patients (92%) had received topical antibiotics. Unsupervised use of topical corticosteroids was observed in 29.2% of the patients for the median duration of 3 days (odds ratio, 0.17). At presentation, the median size of corneal ulcers was 5 mm, the best-corrected visual acuity was less than 20/400 in 51.4% of patients, and corneal perforation was in 14% of patients. The smear and culture positivity rate were 75.4% and 47.9%, respectively. The common causative organism was fungus (48.8%), followed by bacteria (17.4%). Aspergillus spp. and Staphylococcus spp. were the most commonly identified organisms; a quarter of the patients (24.5%) remained unidentified. All bacteria showed good sensitivity to vancomycin.

Conclusion: MK is a significant cause of ocular morbidity in Bihar. The knowledge of epidemiology, risk factors, and microbiological profiles of MK can provide a valuable approach to disease prevention, diagnosis, and management.

Keywords: Bihar; eastern India; epidemiology; microbial keratitis; microbial profile; risk factors; steroid use in keratitis.

Publication types

  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria
  • Corneal Ulcer* / diagnosis
  • Corneal Ulcer* / drug therapy
  • Corneal Ulcer* / epidemiology
  • Eye
  • Eye Infections, Bacterial* / microbiology
  • Female
  • Humans
  • Keratitis* / diagnosis
  • Keratitis* / drug therapy
  • Keratitis* / epidemiology
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-Bacterial Agents